Metabotropic Glutamate Receptor 1-induced Upregulation of NMDA Receptor Current: Mediation Through the Pyk2/Src-family Kinase Pathway in Cortical Neurons
Overview
Authors
Affiliations
The mechanism underlying the upregulation of NMDA receptor function by group I metabotropic glutamate receptors (mGluRs), including mGluR1 and 5, is not known. Here we show that in cortical neurons, brief selective activation of group I mGluRs with (S)-3,5-dihydroxy-phenylglycine (DHPG) induced a Ca(2+)-calmodulin-dependent activation of Pyk2/CAKbeta and the Src-family kinases Src and Fyn that was independent of protein kinase C (PKC). Activation of Pyk2 and Src/Fyn kinases led to increased tyrosine phosphorylation of NMDA receptor subunits 2A and B (NR2A/B) and was blocked by a selective mGluR1 antagonist, 7-(hydroxyamino)cyclopropa[b]chromen-1a-carboxylate ethyl ester, but not an mGluR5 antagonist, 2-methyl-6-(phenylethynyl)pyridine. Functional linkage between mGluR1 activation and NR2A tyrosine phosphorylation through Pyk2 and Src was also demonstrated after expression of these elements in human embryonic kidney 293 cells. Supporting functional consequences, selective activation of mGluR1 by DHPG induced a potentiation of NMDA receptor-mediated currents that was blocked by inhibiting mGluR1 or Src-family kinases. Furthermore, antagonizing calmodulin or mGluR1, but not PKC, reduced the basal tyrosine phosphorylation levels of Pyk2 and Src, suggesting that mGluR1 may control the basal activity of these kinases and thus the tyrosine phosphorylation levels of NMDA receptors.
Synaptic plasticity in human thalamocortical assembloids.
Patton M, Thomas K, Bayazitov I, Newman K, Kurtz N, Robinson C Cell Rep. 2024; 43(8):114503.
PMID: 39018245 PMC: 11407288. DOI: 10.1016/j.celrep.2024.114503.
Synaptic plasticity in human thalamocortical assembloids.
Patton M, Thomas K, Bayazitov I, Newman K, Kurtz N, Robinson C bioRxiv. 2024; .
PMID: 38352415 PMC: 10862901. DOI: 10.1101/2024.02.01.578421.
Astrocyte-neuron circuits in epilepsy.
Purnell B, Alves M, Boison D Neurobiol Dis. 2023; 179:106058.
PMID: 36868484 PMC: 10334651. DOI: 10.1016/j.nbd.2023.106058.
Group I mGluRs in Therapy and Diagnosis of Parkinson's Disease: Focus on mGluR5 Subtype.
Azam S, Jakaria M, Kim J, Ahn J, Kim I, Choi D Biomedicines. 2022; 10(4).
PMID: 35453614 PMC: 9032558. DOI: 10.3390/biomedicines10040864.
Qin Y, Du Y, Chen L, Liu Y, Xu W, Liu Y Mol Psychiatry. 2022; 27(7):2985-2998.
PMID: 35388181 PMC: 9205781. DOI: 10.1038/s41380-022-01539-1.